Ormond's disease
Ormond's Disease, also known as Retroperitoneal Fibrosis, is a rare disorder characterized by the development of fibrous tissue in the area behind the stomach and intestines, known as the retroperitoneal space. This fibrous tissue often encases the ureters, leading to a variety of urinary symptoms.
Etiology[edit | edit source]
The exact cause of Ormond's Disease is unknown. However, it is believed to be associated with certain autoimmune disorders, such as rheumatoid arthritis and systemic lupus erythematosus. It may also be triggered by certain medications, infections, or exposure to specific toxins.
Symptoms[edit | edit source]
The symptoms of Ormond's Disease are often nonspecific and may include abdominal pain, back pain, and unintentional weight loss. As the disease progresses, it may lead to urinary tract obstruction, resulting in symptoms such as frequent urination, urinary urgency, and blood in the urine.
Diagnosis[edit | edit source]
Diagnosis of Ormond's Disease typically involves imaging studies, such as computed tomography (CT) scans or magnetic resonance imaging (MRI). These can reveal the presence of fibrous tissue in the retroperitoneal space. In some cases, a biopsy may be performed to confirm the diagnosis.
Treatment[edit | edit source]
Treatment for Ormond's Disease typically involves managing the symptoms and preventing further progression of the disease. This may include medications to reduce inflammation and slow the growth of fibrous tissue, as well as surgical procedures to relieve urinary tract obstruction.
Prognosis[edit | edit source]
The prognosis for individuals with Ormond's Disease varies. Some individuals may experience a slow progression of the disease with manageable symptoms, while others may experience rapid progression leading to severe urinary tract obstruction and kidney damage.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Ormond's disease is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
